學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Is It Time to Exit Russia? (Commentary for HBR Case Study)
內容大綱
In this fictional case, the CEO of a global pharmaceutical company based in Belgium with operations in Moscow is contemplating what to do in the wake of Russia's invasion of Ukraine in February 2022. The company is experiencing pressure from shareholders, Ukrainian and Belgium government officials, and the public to follow in the footsteps of many multinational corporations and cease operations in Russia. However, since the firm provides medically necessary products, the decision isn't straightforward. How can the CEO navigate the complicated political waters of this decision and make the most humanitarian decision? Should the company exit Russia completely, or should it continue to operate but on a smaller scale? Expert commentators respond.